As of 4:00pm ET
| +0.16 / +1.94%|
The 6 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 15.75, with a high estimate of 34.00 and a low estimate of 10.00. The median estimate represents a +87.28% increase from the last price of 8.41.
The current consensus among 6 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.